Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device.

Literature DB >> 3973000

Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device.

W Bonnez, G Lattimer, N A Mohanraj, T H Johnson.

Abstract

Actinomyces naeslundii is a saprophyte, sometimes a pathogen, of the human oral cavity. Very few extra-oral infections related to this agent have been described. We report the first instance of A. naeslundii as an etiological agent of pelvic actinomycosis in a user of an intrauterine device, an infection so far exclusively attributed to Actinomyces israelii.

Entities: Disease Species

Keywords: Bacterial And Fungal Diseases; Case Studies; Contraception; Contraceptive Methods--side effects; Diseases; Family Planning; Infections; Iud, Unmedicated--side effects; Iud--side effects; Pelvic Infections; Research Methodology; Studies

Mesh：

Year: 1985 PMID： 3973000 PMCID： PMC271633 DOI： 10.1128/jcm.21.2.273-275.1985

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

24 in total

1. Prevalence of Actin-omyces israelii, A. naeslundii, Bacterionema matruchotii, and Candida albicans in selected areas of the oral cavity and saliva.

Authors: A HOWELL; R M STEPHAN; F PAUL
Journal: J Dent Res Date: 1962 Sep-Oct Impact factor: 6.116

2. Actinomycosis of the female genital tract.

Authors: C W Lomax; G M Harbert; W N Thornton
Journal: Obstet Gynecol Date: 1976-09 Impact factor: 7.661

3. Tubo-ovarian actinomycosis and the IUCD.

Authors: D W Purdie; M J Carty; T I McLeod
Journal: Br Med J Date: 1977-11-26

4. Actinomycetes and the IUD: an update.

Authors: P K Gupta; Y S Erozan; J K Frost
Journal: Acta Cytol Date: 1978 Sep-Oct Impact factor: 2.319

5. The Dalkon Shield controversy. Structural and bacteriological studies of IUD tails.

Authors: H J Tatum; F H Schmidt; D Phillips; M McCarty; W M O'Leary
Journal: JAMA Date: 1975-02-17 Impact factor: 56.272

6. Cytologic detection and clinical significance of Actinomyces israelii in women using intrauterine contraceptive devices.

Authors: M R Spence; P K Gupta; J K Frost; T M King
Journal: Am J Obstet Gynecol Date: 1978-06-01 Impact factor: 8.661

2. Recurrent extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection due to an infected intrauterine device.

Authors: Chee-Kin Hui
Journal: Singapore Med J Date: 2014-02 Impact factor: 1.858

Review 3. Pelvic Actinomycosis.

Authors: Alejandra García-García; Ninfa Ramírez-Durán; Horacio Sandoval-Trujillo; María Del Socorro Romero-Figueroa
Journal: Can J Infect Dis Med Microbiol Date: 2017-06-08 Impact factor: 2.471

3 in total

Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device.

1. Prevalence of Actin-omyces israelii, A. naeslundii, Bacterionema matruchotii, and Candida albicans in selected areas of the oral cavity and saliva.

2. Actinomycosis of the female genital tract.

3. Tubo-ovarian actinomycosis and the IUCD.

4. Actinomycetes and the IUD: an update.

5. The Dalkon Shield controversy. Structural and bacteriological studies of IUD tails.

6. Cytologic detection and clinical significance of Actinomyces israelii in women using intrauterine contraceptive devices.

7. Susceptibility of pathogenic actinomycetes to antimicrobial compounds.

8. Microbiota of gingivitis in man.

9. Genital actinomycosis and intrauterine contraceptive devices. Cytopathologic diagnosis and clinical significance.

10. Actinomyces naeslundii as an agent of human actinomycosis.

Review 1. Actinomyces israelii in the female genital tract: a review.

2. Recurrent extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection due to an infected intrauterine device.

Review 3. Pelvic Actinomycosis.